Real-time enrollment status for this metastatic breast cancer clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 8:42 AM UTC
| NCT Number | NCT07524855 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Breast Cancer |
| Phase | PHASE1 |
| Target Enrollment | 170 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Halda Therapeutics OpCo, Inc. |
| Last Updated on CT.gov | August 17, 2026 (1 week ago) |
As of August 30, 2026: Clinical trial NCT07524855 is currently recruiting participants. This phase1 study for metastatic breast cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by Halda Therapeutics OpCo, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07524855 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07524855 was last updated 1 week ago (August 17, 2026). HelloStudys verifies this status automatically.